Symptomatic benefit and metabolic cost of adding olanzapine to risperidone in schizophrenia: an 8-week retrospective cohort study

Authors

Institutions

Publication Details

Journal
BMC Psychiatry
Published
2026-10-17
DOI
https://doi.org/10.1186/s12888-026-08766-8
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Symptomatic benefit and metabolic cost of adding olanzapine to risperidone in schizophrenia: an 8-week retrospective cohort study

Yinbo Li, Liang Shen, Han Xingling, Jia Shen et al.
BMC Psychiatry
Schizophrenia research and treatment
article

Symptomatic benefit and metabolic cost of adding olanzapine to risperidone in schizophrenia: an 8-week retrospective cohort study

Yinbo Li, Liang Shen, Han Xingling, Jia Shen, Hangping Li, Fang Shen
article en

Abstract

No abstract available for this paper.
BMC Psychiatry
Fuyang City People's Hospital (CN), Tongde Hospital of Zhejiang Province (CN), Third People's Hospital of Hangzhou (CN)
Good health and well-being
Openalex Percentile: Top 13%
Schizophrenia research and treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.